The hemodynamic responses to isoproterenol and dopamine were investigated in 22 patients with the shock syndrome from various etiologies. Dopamine was superior to isoproterenol in seven patients with normal or low peripheral resistance. In this group of patients administration of isoproterenol was associated with unacceptably low blood pressure. Isoproterenol was superior in three patients in whom dopamine did not increase cardiac output. Both amines produced adequate clinical response in four patients, and a combination of isoproterenol and dopamine was necessary for adequate therapy in two patients. Six patients did not respond hemodynamically or clinically to either dopamine or isoproterenol. This investigation has demonstrated that optimal sympathomimetic amine therapy of shock is facilitated by an analysis of hemodynamic status and responses to drug administration.
SUMMARY
The hemodynamic responses to isoproterenol and dopamine were investigated in 22 patients with the shock syndrome from various etiologies. Dopamine was superior to isoproterenol in seven patients with normal or low peripheral resistance. In this group of patients administration of isoproterenol was associated with unacceptably low blood pressure. Isoproterenol was superior in three patients in whom dopamine did not increase cardiac output. Both amines produced adequate clinical response in four patients, and a combination of isoproterenol and dopamine was necessary for adequate therapy in two patients. Six patients did not respond hemodynamically or clinically to either dopamine or isoproterenol. This investigation has demonstrated that optimal sympathomimetic amine therapy of shock is facilitated by an analysis of hemodynamic status and responses to drug administration.
Additional Indexing Words: Hemodynamics of shock
Cardiac output DOPAMINE is a naturally occurring catecholamine which increases myocardial contractile force by a beta-adrenergic action and produces mild vasoconstriction by an alpha-adrenergic action.' Dopamine also produces renal2 3 and mesenteric vasodilation4 by a direct specific action, not antagonized by either alpha or beta-adrenergic blocking agents. This unique combination of properties provides a rational basis for the use of dopamine in treatment of the shock syndrome in man. Encouraging evidence of clinical value was found in a series of 11 patients who were hypotensive or in shock. 5 Currently, isoproterenol occupies a position of prominence in the treatment of shock syndrome unresponsive to volume expansion, regardless of etiology.6-8 Isoproterenol pro- Circuelation, Vojlutne XXXIX, March 1969 Peripheral resistance duces cardiac stimulation and mesenteric and peripheral vasodilation by action on betaadrenergic receptors. It has been proposed that isoproterenol benefits patients in shock by both reducing vasoconstriction when present and improving cardiac performance.8 9 However, unfavorable responses to isoproterenol, including rapidly fatal cardiovascular deterioration, have also been reported.'0'1'
The present study was designed to compare the hemodynamic effects of dopamine and isoproterenol in patients in shock. Methods The shock syndrome was defined as inadequate organ perfusion manifested by the following physiological abnormalities: decreased mental acuity, oliguria, slow nail-bed capillary filling, pallor, cool skin, tachycardia, collapsed veins, and poor peripheral pulse. Although abnormally low blood pressure is not invariably present in the shock syndrome, all patients in our series had a mean arterial pressure of less than 62 mm Hg. Patients were referred from all adult in-patient services at Grady Memorial Hospital, the majority coming from the medical service. This method of obtaining patients limited the study in the following ways. First, patients were rarely referred unless 361 initial treatment by the attending physician was unsuccessful. Therefore, patients were seldom in a "steady state," but were progressively deteriorating clinically as is characteristic of the shock state. Second, since treatment was frequently begun with isoproterenol prior to referral, randomization of administration of the two agents was not always possible.
Central venous pressures were measured through indwelling polyethylene catheters inserted into the superior vena cava or right atrium through basilic, cephalic, external jugular, or subclavian veins. Venous pressures were measured with water manometers using one half the chest thickness as the right atrial level. Femoral arterial pressures were measured by Statham pressure transducers via indwelling Teflon catheters. The mean arterialpressure was obtained electronically. All patients received assisted respiration and sodium bicarbonate infusions when indicated on the basis of clinical evaluation and arterial blood gas and pH measurements. Electrocardiograms were recorded on all patients. The urinary bladder was catheterized and air washes were used at timed intervals for measurements of urine flow.
Cardiac output was estimated by the dyedilution technique using indocyanine green dye. A fixed 1 ml dye volume followed by 10 ml of 5% dextrose in water was rapidly injected through the central venous catheter. Blood was withdrawn from the femoral artery at constant speed with a Harvard syringe driving pump, and dye concentration was measured by a Waters X 301 densitometer. All cardiac output determinations were performed in duplicate, and the results presented are averages of these duplicate values. The blood withdrawn for determination of cardiac output was not replaced. The total blood withdrawn over the 8 hr study period never exceeded 350 ml, and for an individual measurement of cardiac output it never exceeded 20 ml. There was no evidence that such removal affected central venous pressure, arterial pressure, or sequential cardiac outputs. Although the dyedilution technique of estimating cardiac output is somewhat inaccurate at very low cardiac outputs, it is generally accepted as reliable for comparison of outputs in an individual patient over a short period, as in this study.5"10 1' Parameters were recorded on a Honeywell Visicorder 1108 oscillograph. Areas under dyedilution curves were determined by means of logarithmic extrapolation.12 Peripheral resistance was calculated by the following formula: mean arterial pressure minus central venous pressure (mm Hg) /cardiac output (L/min) and was expressed as peripheral resistance units (PRU).13 Normal values range from 15 to 19 PRU.
Prior to the administration of sympathomimetic amines all patients were given a 15 to 30 min infusion of 250 to 500 ml of 6% dextran in normal saline or saline alone with constant monitoring of central venous pressure. Patients who tolerated the initial infusion were given additional intravenous fluids until the central venous pressure was 11 cm H20 or greater. Only patients who failed to improve clinically or hemodynamically, or both following this expansion were included in this study.
Dopamine and isoproterenol were diluted in 5% dextrose in water and administered by intravenous infusion. In order to establish the optimal rate of administration of each drug for a given patient, varying doses beginning at an empirically established lowest effective dose were evaluated clinically and hemodynamically. Only those results obtained at an infusion rate producing the hemodynamic and clinical response considered optimal are reported. Doses of dopamine ranged from 1 to 18 ,ug/kg/min, and doses of isoproterenol ranged from 0.01 to 0.16 pug/kg/min. Hemodynamic measurements were obtained at least 30 min following the institution of drug infusion which allowed the full effect to develop.
Similarly, at least 30 min was allowed after discontinuing either drug to permit subsidence of its effect. Measurements during periods without drug administration were obtained prior to amine therapy or at least 30 min after discontinuation of all drug therapy. Such data could not be obtained in nine of 22 patients. In these instances, discontinuation of amine infusion for a sufficient period to permit hemodynamic stabilization was considered potentially detrimental to patient welfare. Sequence of administration of the drugs was randomized unless patients were on one of the study drugs when first seen. The amine or combination of amines judged to be most beneficial on the basis of the hemodynamic and clinical studies was continued in each patient until recovery or death. Patients who survived the acute period of shock and lived for at least 8 hr after discontinuation of all sympathomimetic amines without clinical manifestations of the shock syndrome were classified as "shock survival." Isoproterenol HCI was obtained as Isuprel* (1 mg ampules) and dopamine HCI as Intropint (200 mg ampules).
Results
A total of 22 patients was studied. On the basis of clinical and hemodynamic responses to isoproterenol and dopamine the patients were divided into five groups. Group I consists of six patients who failed to respond to either drug. Group II consists of three patients whose response to isoproterenol was significantly superior than their response to dopamine. Group III is composed of seven patients whose hemodynamic and clinical response to dopamine was clearly superior to that of isoproterenol. Group IV includes four patients who responded adequately to either isoproterenol or dopamine. Group V is composed of two patients whose best clinical and hemodynamic values were obtained by the simultaneous administration of both drugs. Table 1 presents a summary of the clinical data from each patient, including presumed etiology of the shock syndrome, survival, medications received prior to or during the study period, and a brief comment on the response to therapy. The times at which various medications were administered are indicated by referring to the beginning of the study period as time zero. The patients were categorized into the five groups defined above. Table 2 presents the cardiac output, mean arterial pressure, venous pressure, peripheral resistance, urine flow, and arterial pH of each patient during administration of the optimal dose of each drug and during control periods. Table 2 includes estimates of the duration of shock prior to beginning each study. The times at which the hemodynamic measurements were performed are shown, also using the beginning of the study as zero reference time.
The etiology of the shock syndrome in the six patients comprising group I included sepsis, drug ingestion, and myocardial infarction. These patients failed to respond to either isoproterenol or dopamine by hemodynamic or clinical improvement (tables 1 and 2). This was true despite early institution of therapy after the apparent onset of shock and despite fairly acceptable values for pH in patients 6 and 17. When obtained, the control hemodynamic values revealed low cardiac output and low or low-normal peripheral resistance in all patients except pa-t) m 00 00o
. . Ot-10OO 00 C0 co Course during study period of patient 4, P.W., a 73-year-old male with gram-negative sepsis.
Upon infusion of isoproterenol the central venous pressure and arterial pressure fell. With continuation of isoproterenol and volume replacement there was an increase in cardiac output and arterial pressure. tient 10. However, these hemodynamic characteristics did not differentiate the group I patients from those of groups 1I through V, who responded to either or both of the drugs. Other medications were studied in these patients, and except for a poorly sustained rise in resistance following norepinephrine infusion in several of the patients, no response was obtained. The reasons for the lack of clinical and hemodynamic response of these patients remain unclear.
Group II (Shock Survival 1/3) This group consists of three patients whose clinical and hemodynamic response to isoproterenol was significantly superior to that of dopamine. Two of these, patients 4 and 9 (tables 1 and 2), responded to isoproterenol with a dramatic fall in central venous pressure.
The central venous pressure of each patient was elevated after volume expansion alone and during the infusion of dopamine. Dopamine happened to be the first drug administered in each of these two patients. With the continuation of isoproterenol and the addition of fluids, striking improvements in cardiac output, blood pressure, and clinical status occurred in both cases. Patient 4, P.W., illustrated this response: Patient 4 (P.W.), a 73-year-old male, was admitted to the urology service because of symptoms of lower urinary tract obstruction. There was an antecedent history of hypertension with previous blood pressure recordings as hiigh as 240/140. Despite bladder drainage and conservative management the patient's blood urea nitrogen rose from 54 to 100 mg % over the next difficulties prevented retrograde ureteral catheterization. Thirty-six hours prior to transfer to the medical service the patient's temperature rose abruptly to 103F, and he became hypotensive, confused, and anuric. Blood cultures subsequently grew out E. Coli. He was treated with intravenous hydrocortisone, kanamycin, and ampicillin. Aggressive fluid administration resulted in elevation of venous pressure without change in blood pressure or clinical improvement. The patient was studied over a 7 hr period beginning approximately 7 hr after arrival on the medical service. A summary of the hemodynamic findings during the study is illustrated in figure 1 . Control studies revealed cardiac output of 2.1 L/min, mean arterial pressure of 48 mm Hg, and peripheral resistance of 18.6 PRU. The central venous pressure was 12 cm H20. Dopamine was infused at several different rates, and although the mean arterial pressure rose to 86 mm Hg, this was associated with a doubling of the peripheral resistance without an increase in cardiac output. Central venous pressure remained at 12 cm H20. Isoproterenol initially produced a transient rise in the mean arterial pressure but later it decreased to below control levels. This fall of the mean arterial pressure coincided with a fall in the central venous pressure to zero. With further fluid administration the mean arterial pressure again rose due to an increase in the cardiac output to 6.3 L/min, three times the control level. Peripheral resistance fell to 12.6 PRU. Despite continued adequate blood pressure during isoproterenol infusion the patient died 24 hr after completion of the hemodynamic study. At postmortem examination the cause of anuria was found to be right ureteral occlusion by a large right iliac arterial aneurysm and left ureteral occlusion by a large walled-off purulent bladder diverticulum. Examination of the kidneys revealed bilateral pyelonephritis with multiple bacterial and fungal abscesses. The third patient of group II (patient 21, T.H., tables 1 and 2) was initially placed on a low dose of dopamine (2 ,ig/kg/min) to obtain a diuresis as part of the therapy of congestive heart failure secondary to an acute myocardial infarction.'4 Hypotension subsequently developed, and the dose of dopamine was increased to 8 ,ug/kg/min in order to maintain systolic pressure at 90 mm Hg. Because discontinuation of dopamine was associated with a fall in blood pressure to unobtainable levels and seizure activity, dopamine infusion was restarted. Hemody-Circulation, Volume XXXIX, March 1969 namic study revealed that peripheral resistance was twice normal. After substitution of isoproterenol for dopamine mean arterial pressure remained unchanged, but peripheral resistance decreased to normal and cardiac output and urine flow increased.
Group III (Shock Survival 5/7) This group includes seven patients whose response to dopamine was clearly superior, both clinically and hemodynamically, to that of isoproterenol. In five of the seven patients isoproterenol administration was probably detrimental (tables 1 and 2). Analysis of the hemodynamic responses of these patients is facilitated by examination of figure 2 . Peripheral resistance units are plotted on the abscissa and mean arterial pressure minus central venous pressure on the ordinate. Radial lines drawn through the origin designate constant cardiac outputs 2.5, 5, and 10 L/min. Control values are designated by squares, values obtained during isoproterenol infusion by circles, and values obtained during dopamine infusion by triangles. Urine flows during infusion of each drug are shown in the right upper corner of figure 2, and may be matched to the hemodynamic conditions by the patients' identification numbers.
Peripheral resistance was low and cardiac output was nornal or low in each of the three patients whose condition permitted control studies. During treatment with isoproterenol the peripheral resistance was low in all patients in this group, being less than 10.5 PRU in all seven. Although in some cases isoproterenol was associated with normal or elevated cardiac output (table 2, fig. 2 ), mean arterial pressures were probably too low for adequate tissue perfusion as indicated by the lack of urine flow and desperate clinical state of the patients. Dopamine infusion was associated with marked clinical and hemodynamic improvement in each case. The peripheral resistance increased, returning to normal values in five of seven cases. This rise in the peripheral resistance, in association with a cardiac output equal to or greater than that noted during isoproterenol infusion in six of the Graphic presentation of hemodynamic responses of patients in group III at control states (squares) and with isoproterenol (circles), and dopamine (triangles) infusions. Peripheral resistance units are plotted on the abscissa and mean arterial pressure minus central venous pressure (mm Hg) on the ordinate. Radial lines drawn through the origin designate constant cardiac outputs. Urine flows during infusion of each drug are shown in the right upper corner and may be matched to the hemodynamic conditions by the patients' identification numbers. seven patients, resulted in an increase in the mean arterial pressure in all patients. The increased perfusion pressure, possibly coupled with the renal vasodilating effect of dopamine, was associated with urine flow in all patients, three of whom had been anuric prior to dopamine infusion. Three of the seven patients in this group survived to leave the hospital. The following case history is presented as an example of this group. Figure 3 graphically presents the hemodynamic values obtained during the study period.
Patient 12 (L.H.), a 53-year-old female, entered the hospital in a coma. Her family related that she began to "feel bad" 6 days prior to admission. For 2 days prior to admission she remained in bed, and 1 day prior to admission she was noted to be "breathing hard." On the day of admission, she "acted out of her head" and subsequently became unresponsive. Physical examination on admission revealed a blood pressure of 50/0, pulse rate of 110 and respiratory rate of 24/min. Urine, obtained via an indwelling bladder catheter, was positive for sugar and acetone. Laboratory values were as follows: sodium, 150 mEq/L; potassium, 5.5 mEq/L; chloride, 107 mEq/L; bicarbonate, 7.0 mEq/L; blood urea nitrogen, 118 mg%; blood sugar, 1600 mg%. Treatment of diabetic ketoacidosis with insulin and fluids was institued. Over the next 12 hr 5 L of normal saline, 3.5 L of one-half normal saline, and 2.5 L of glucose and water were infused along with insulin. Despite a rise in the central venous pressure from 5 to 14 cm H0O, no urine output was obtained. Blood pressure initially rose slightly during a brief infusion of metaraminol but subsequently fell. Twelve hours after admission the following laboratory values were obtained: arterial pH, 7.34; sodium, 153 mEq/L; potassium, 3.8 mEq/ L; chloride 122 mEq/L; bicarbonate, 16 .5 mEq/ L; blood urea nitrogen, 86 mg%; blood sugar, 340 mg%. The patient appeared agitated, unresponsive to command, and in a moribund state, although the extremities were warm and capillary flow was judged to be fair. At this point, hemodynamic study revealed central venous pressure of 14 cm H20, cardiac output of 5.7 L/min, mean arterial pressure of 41 mm Hg, and peripheral resistance of 5.4 PRU. During isoproterenol infusion mean arterial pressure fell to 37 mm Hg despite an increase in cardiac output to 7.4 L/min; peripheral resistance fell to 4.1 PRU, and the central venous pressure was 9.5 cm H20. The patient remained unresponsive and anuric. During subsequent dopamine infusion the mean arterial pressure rose to 67 mm Hg while the cardiac output remained unchanged at 7.5 L/min. The peripheral resistance rose to 7.9 PRU. Central venous pressure was 11.0 cm H20. Urine flow was noted for the first time and was sustained at a rate of 0.7 to 1.0 cc/min (table 2, fig. 3 ). The patient's agitation ceased and she responded to commands. This group includes four patients whose clinical and hemodynamic responses to both isoproterenol and dopamine were considered adequate (tables 1 and 2, fig. 4 ). The control peripheral resistances of these patients were normal. Although the peripheral resistances declined during isoproterenol infusion, they were in all cases greater than those observed during isoproterenol infusion in group III, where isoproterenol seemed deleterious. The response to isoproterenol of the patients in group IV was characterized by an increase in both cardiac output and mean arterial pressure. The hemodynamic pattern was one of proportionally greater increase in cardiac output than decrease in peripheral resistance, with resultant rise in mean arterial pressure. Dopamine also increased both cardiac output and mean arterial pressure in this group of patients. However, in contrast to isoproterenol, an increase in peripheral resistance in three of the four patients was observed. In one case the peripheral resistance decreased. Urine flow, while adequate on each drug, was somewhat greater with dopamine (table 2, fig. 4 ). The following case report is presented as an example from this group of patients. The hemodynamic data are presented graphically in figure 5 . Urine flow and blood pressure were maintained during isoproterenol infusion. However, gradual clinical deterioration was probably occurring, since the dose of isoproterenol had to be doubled 12 hr after the cardiac arrest and shortly before the hemodynamic studies were performed. At the time of study the patient was responsive, warm, and forming urine at a rate of 5 ml/min. Hemodynamic values during isoproterenol infusion were: cardiac output 4.0 L/min, mean arterial pressure 58 mm Hg, and peripheral resistance 12.9 PRU. After discontinuation of isoproterenol, cardiac output was 2.5 L/min, mean arterial pressure 45 mm Hg, and peripheral resistance 13.2 PRU. The patient became anuric and agitated. His skin was cool and moist. At this point, an infusion of dopamine was started. Cardiac output increased to 3.5 L/min, mean arterial pressure to 68 mm Hg, peripheral resistance to 17.0 PRU., and urine flow to 5 ml/min (table 2, fig. 5 ). The skin became warm and tlie agitation subsided. Dopamine infusion was continued at a rate of 6 Course during study period of patient 22, R.H., a 60-year-old male with gram-negative pneumonia and alcoholism. Isoproterenol and dopamine infusions were associated with adequate arterial pressure, cardiac output, and urine flow. patient began to hallucinate and became tremulous. It was felt that he had developed delerium tremens. Two hours later his blood pressure and urine output fell and his skin again became cool and moist. Isoproterenol was substitued for dopamine, but no clinical improvement was observed. The patient continued to deteriorate clincially and died 4 hr later.
Group V (Shock Survival 0/2) The two patients in this group, one with sepsis and the other with a myocardial infarction, responded favorably hemodynamically to isoproterenol, but urine flow was very low (tables 1 and 2). Small doses of dopamine (1 to 2 ug/kg/min) resulted in higher urine flow but lower cardiac output than seen during isoproterenol infusion. Larger doses of dopamine increased both cardiac output and mean arterial pressure, but urine flow decreased. A combination of isoproterenol and small doses of dopamine (table 2) produced (irculaizon, Volume XXXIX, March 1969 an acceptable arterial pressure with higher levels of cardiac output and urine production than were observed during administration of either drug alone. Although both patients showed clinical improvement during the combined drug administration, neither survived. The results of hemodynamic studies of the following illustrative case are presented in figure 6 . Patient 8 (F.Z.), a 75-year-old male, was unresponsive when admitted with a left bemiparesis and no palpable blood pressure or pulse. Later, history revealed chest pains in the recent past and heart failure treated at another hospital. An infusion of isoproterenol was started in the emergency room, and hemodynamic studies were obtained 5 hr later. During isoproterenol infusion cardiac output was 5.2 L/min, mean arterial pressure 75 mm Hg, peripheral resistance 9.8 PRU, and central venous pressure 31 cm H20. Urine flow was minimal. During infusion of large doses of dopamine the mean arterial pressure was adequate, but urine flow did not increase.
On a small dose of dopamine (1 ,ug/kg/min) cardiac output was 3.2 L/min, mean arterial pressure 73, peripheral resistance 16.0 PRU, and central venous pressure 29 cm H20. Urine flow was 0.2 ml/min. Isoproterenol infusion was restarted and the low infusion rate of dopamine maintained. During combined drug administration the cardiac output rose to 7.7 L/min, the mean arterial pressure was 73 mm Hg, the peripheral resistance 6.8 PRU, and central venous pressure 25 cm H20. Urine flow increased to 0.3 ml/min and later rose to 1.0 ml/min (table 2, fig. 6 ). The patient was noted to make purposeful movements at this point and his cough reflex returned. He did not, however, respond to command. For the next 193 hr while the combination therapy was continued the patient seemed to make some clinical improvement. However, cardiac arrest with asystole occurred, and the patient could not be resuscitated. Postmortem examination revealed an acute anteroseptal myocardial infarction, an old anterior myocardial infarction, and an old occlusion of the right coronary artery. The neurological signs were secondary to a right middle cerebral artery occlusion. 
Adverse Effects
In addition to those patients whose responses were judged to be hemodynamically detrimental, supraventricular tachycardia occurred in patient A. H. (no. 13) during infusions of dopamine (6 ,ug/kg/min), and isoproterenol (0.06 ,ug/kg/min). The arrhythmia spontaneously reverted with discontinuance of the infusions. Resumption of administration of both amines at lower rates was unaccompanied by arrhythmia.
Discussion
This investigation has confirmed previous studies which demonstrated that both dopamine and isoproterenol are effective agents for the treatment of certain patients in shock.5-7 In addition, hemodynamic measurements have provided information concering the mechanism by which these amines may be Course during study period of patient 8, F.Z., a 75-year-old male with an acute myocardial infarction and left hemiparesis. The simultaneous administration of isoproterenol and dopamine was associated with a greater cardiac output and urine flow than that achieved on either drug alone. The two vertical lines signify arterial pressure readings obtained by aicultation at the times indicated. Arterial pressure by auscultation and peripheral pulse were unobtainable at other times during this period. Circulation, Volume XXXIX, March 1969 beneficial when administered to some patients and detrimental to others. The most significant hemodynamic difference between isoproterenol and dopamine was their effect on peripheral resistance. This difference was clearly demonstrated to be of clinical importance in the patients in group III. In these seven patients in whom dopamine was considered to be superior to isoproterenol, the peripheral resistance was considerably lower during isoproterenol administration than during dopamine administration. Since the cardiac output was maintained at similar levels with both amines, blood pressure was lower in each patient during the isoproterenol infusion and appeared to be too low to maintain perfusion pressure of vital organs in several patients. Similar adverse hemodynamic responses to isoproterenol were reported by Gunnar and associates'0 and Smith and co-workers."
On the other hand, reduction of peripheral resistance was apparently not detrimental in three patients whose response to isoproterenol was considered to be superior to that of dopamine (group II). In two of these patients (nos. 4, P.W., and 9, J.W.) isoproterenol administration was associated with a precipitous fall in central venous pressure. Continuation of the isoproterenol infusion and additional fluid administration resulted in pronounced increments in cardiac output and clinical improvement. Isoproterenol produced a greater increase in cardiac output than dopamine in the third patient in the group (no. 21, T.H.) and also lowered the abnormally high peripheral resistance which was present during the dopamine infusion. The increased cardiac output at unchanged or increased arterial pressure and decreased preload (central venous pressure) implies a positive inotropic effect of isoproterenol. This difference between the two agents was particularly evident in patient 4 in whom isoproterenol produced a threefold greater increase in cardiac output than dopamine at the same level of mean arterial pressure (afterload) and at a lower central venous pressure. It is possible that larger doses of Circulation, Volume XXXIX, March 1969 dopamine would have produced greater myocardial stimulation. However, in this patient it was not considered clinically appropriate to increase the dose of the amine due to the elevation of the peripheral resistance which occurred during dopamine infusion.
Effects on peripheral resistance did not appear to be of decisive clinical importance in the four patients who responded adequately to both dopamine and isoproterenol (group IV). The increase in cardiac output produced by both amines was proportionally greater than the changes in peripheral resistance. Renal function, as reflected by urine formation, was also improved by both amines but more so by dopamine in three of the four patients. This difference may be attributable to the specific renal vasodilating action of dopamine. However, a higher renal perfusion pressure during dopamine administration cannot be excluded as a mechanism of the effect.
The contrasting responses to isoproterenol and dopamine emphasize their pharmacological differences. Although infusions of both amines in normal subjects increase cardiac output and reduce total peripheral resistance they should not be grouped together in a single category designated by such a term as "vasodilator." Isoproterenol acts upon betaadrenergic receptors to produce vasodilation with predominant effects occurring in the skeletal muscle and mesenteric vascular beds. 15 Although administration of isoproterenol into the renal artery causes renal vasodilation,3 renal blood flow usually does not increase when the amine is administered intravenously.2' "' The peripheral vascular actions of dopamine are more complex. Vasodilation is produced in the renal2 3 and mesenteric4 vascular beds by a nonadrenergic mechanism. The predominant effect produced in the skeletal muscle beds is vasoconstriction secondary to action on alpha-adrenergic receptors.1 3, 17 Because of the diverse vascular actions of dopamine, peripheral resistance may either increase or decrease. In general, small doses of dopamine tend to decrease peripheral resistance while large doses increase peripheral resistance. In this study the infusion rate of dopamine required to obtain optimal clinical and hemodynamic effects was usually associated with an increase in peripheral resistance. Unlike isoproterenol renal blood flow usually increases with intravenous administration of dopamine.2 "18 As has been frequently emphasized, a drug with vasoconstricting properties may be harmful to a patient in shock if such vasoconstriction occurs in the renal and mesenteric vascular beds. The increase in urine flow produced by dopamine in the majority of patients suggests that the renal vascular bed was not adversely constricted by dopamine. Further evidence that the degree of vasoconstriction produced by dopamine was not necessarily harmful was obtained in the patients who received dopamine for prolonged periods. One patient (no. 15, M.M.) remains well after receiving dopamine continuously for 68 hr; a second patient (no. 16, D.S.) survived the shock episode after 72 hr of dopamine infusion. Two methods have been found useful in reducing potentially excessive vasoconstriction produced by dopamine. In the present study, concomitant administration of dopamine and isoproterenol produced greater increases in cardiac output and urine flow (group V) for selected patients than did either amine alone. These data suggest that this combination results, in addition, in possible potentiation of the cardiac stimulating effects of these amines and minimizes the danger of excessive vasoconstriction by dopamine and excessive vasodilation by isoproterenol. In a previous investigation of the use of dopamine in shock a case was reported in which administration of the alpha-adrenergic blocking agent, phenoxybenzamine (Dibenzyline), prevented a reduction in urine flow which had occurred when the dopamine infusion rate was increased before administration of the alphaadrenergic blocking agent.5 A similar salutary effect of the combination of phenoxybenza-mine and dopamine had been observed in another patient not reported here. 19 In addition to comparing dopamine and isoproterenol, this study and others20'21 demonstrate the variable hemodynamic status of patients with the shock syndrome. Such variability has been observed even when cases of shock attributed to a single etiology are studied.22 24 Although we found it clinically possible to obtain hemodynamic data in the absence of sympathomimetic amine administration in only 13 of 22 patients, the peripheral resistance was low in 11 of these. Low peripheral resistance has been reported to occur in patients with "septic shock"22 and shock following myocardial infaction. 11, 24 In the present investigation the low peripheral resistance may have been the consequence of either a pathological process or prior isoproterenol administration.
As with most clinical investigations of new drugs for the treatment of shock, many of our patients were studied after conventional therapy had failed. It was anticipated, therefore, that a high percentage of the patients would succumb to the pathological processes responsible for the shock syndrome. Nevertheless eight of the 22 patients (36%o) recovered from the acute shock period and lived for at least 8 hr without sympathomimetic amine therapy, and five patients left the hospital alive.
Since a variety of derangements in the central venous pressure, cardiac output, and peripheral resistance may be present in the shock syndrome in humans regardless of the etiology, it seems reasonable that no single drug would be adequate to correct the hemodynamics in all cases of shock. This study suggests that a reasonable approach to the treatment of the shock syndrome would consist of monitoring the central venous pressure before and after a trial of volume expansion. In patients who fail to respond to volume expansion, optimal drug or combination drug therapy appears to be obtainable only by sequential administration with serial hemodynamic and clinical evaluations of each drug's effects. Our data suggest that both Circulation, Volume XXXIX, March 1969 isoproterenol and dopamine may be of value for selected patients. More potent vasoconstrictor agents such as norepinephrine or metaraminol may be required if adequate perfusion pressure cannot be obtained with either dopamine or isoproterenol.l10l1 Finally, it should be emphasized that dopamine is presently under investigation. Although one group has thus far confirmed the value of dopamine in clinical shock,25 many more patients will have to be studied to determine whether the unusual pharmacological actions of dopamine will provide a new therapeutic approach for the treatment of shock. On Responsibility The gist of it all is that you won't attain any educational goal by thumbing xides in the rumble seat of a college curriculum; you must take the wheel, find the self-starter in yourself, and step on it. Don't resent it if the faculty does some back-seat driving, for they have gone over this route before. You can easily ditch yourself and all our hopes for you if you let your purposes wander and miss the warnings or steer for soft spots 
